AEON Biopharma (AEON) Competitors $0.85 +0.01 (+0.71%) Closing price 07/3/2025 03:47 PM EasternExtended Trading$0.86 +0.01 (+1.30%) As of 07/3/2025 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEON vs. LTRN, KZR, OKUR, BDRX, RNTX, KALA, MRNS, EYEN, DYAI, and ALLKShould you be buying AEON Biopharma stock or one of its competitors? The main competitors of AEON Biopharma include Lantern Pharma (LTRN), Kezar Life Sciences (KZR), OnKure Therapeutics (OKUR), Biodexa Pharmaceuticals (BDRX), Rein Therapeutics (RNTX), KALA BIO (KALA), Marinus Pharmaceuticals (MRNS), Eyenovia (EYEN), Dyadic International (DYAI), and Allakos (ALLK). These companies are all part of the "pharmaceutical products" industry. AEON Biopharma vs. Its Competitors Lantern Pharma Kezar Life Sciences OnKure Therapeutics Biodexa Pharmaceuticals Rein Therapeutics KALA BIO Marinus Pharmaceuticals Eyenovia Dyadic International Allakos Lantern Pharma (NASDAQ:LTRN) and AEON Biopharma (NASDAQ:AEON) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability. Do analysts recommend LTRN or AEON? Lantern Pharma presently has a consensus price target of $25.00, suggesting a potential upside of 686.16%. AEON Biopharma has a consensus price target of $360.00, suggesting a potential upside of 42,453.19%. Given AEON Biopharma's higher possible upside, analysts plainly believe AEON Biopharma is more favorable than Lantern Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lantern Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00AEON Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger valuation & earnings, LTRN or AEON? Lantern Pharma is trading at a lower price-to-earnings ratio than AEON Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLantern PharmaN/AN/A-$20.78M-$1.84-1.73AEON BiopharmaN/AN/A-$36.63M$298.120.00 Do institutionals & insiders hold more shares of LTRN or AEON? 28.6% of Lantern Pharma shares are held by institutional investors. Comparatively, 22.8% of AEON Biopharma shares are held by institutional investors. 7.3% of Lantern Pharma shares are held by insiders. Comparatively, 0.9% of AEON Biopharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to LTRN or AEON? In the previous week, Lantern Pharma had 1 more articles in the media than AEON Biopharma. MarketBeat recorded 1 mentions for Lantern Pharma and 0 mentions for AEON Biopharma. Lantern Pharma's average media sentiment score of 1.53 beat AEON Biopharma's score of 0.00 indicating that Lantern Pharma is being referred to more favorably in the media. Company Overall Sentiment Lantern Pharma Very Positive AEON Biopharma Neutral Is LTRN or AEON more profitable? AEON Biopharma's return on equity of 0.00% beat Lantern Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Lantern PharmaN/A -83.26% -70.65% AEON Biopharma N/A N/A -994.63% Which has more risk and volatility, LTRN or AEON? Lantern Pharma has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500. Comparatively, AEON Biopharma has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. SummaryLantern Pharma beats AEON Biopharma on 7 of the 11 factors compared between the two stocks. Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AEON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEON vs. The Competition Export to ExcelMetricAEON BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.56M$812.96M$5.56B$9.05BDividend YieldN/A4.84%5.24%3.99%P/E Ratio4.701.1527.6520.23Price / SalesN/A230.41419.56119.26Price / CashN/A23.4426.2128.59Price / Book-0.216.328.035.65Net Income-$36.63M-$27.99M$3.18B$249.15M7 Day Performance11.46%2.10%2.93%3.28%1 Month Performance3.80%9.39%1.72%3.95%1 Year Performance-98.80%11.51%34.39%20.98% AEON Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEONAEON Biopharma3.5046 of 5 stars$0.85+0.7%$360.00+42,453.2%-98.8%$9.56MN/A4.705Gap UpLTRNLantern Pharma2.4492 of 5 stars$3.16-0.9%$25.00+691.1%-27.4%$34.07MN/A-1.7220News CoveragePositive NewsKZRKezar Life Sciences4.1964 of 5 stars$4.58+3.2%$39.50+762.4%-21.4%$33.48M$7M-0.4260OKUROnKure Therapeutics2.942 of 5 stars$2.39-0.4%$32.33+1,252.9%N/A$32.29MN/A-0.45N/ABDRXBiodexa Pharmaceuticals0.6935 of 5 stars$0.87-0.6%N/AN/A$31.61M$470K0.0020Positive NewsUpcoming EarningsRNTXRein TherapeuticsN/A$1.40-4.8%N/AN/A$31.01MN/A-0.499KALAKALA BIO3.3713 of 5 stars$4.76+3.0%$13.50+183.6%-23.3%$30.71MN/A-0.5830MRNSMarinus Pharmaceuticals2.3188 of 5 stars$0.55-0.2%$3.92+613.3%-54.2%$30.32M$30.99M-0.22110News CoverageEYENEyenovia2.6195 of 5 stars$10.38-4.6%$2.00-80.7%-77.1%$29.89M$60K-0.1840Analyst UpgradeHigh Trading VolumeDYAIDyadic International1.9943 of 5 stars$0.99-0.9%$6.00+506.1%-35.3%$29.79M$3.49M-4.957News CoverageGap DownALLKAllakos2.8718 of 5 stars$0.33flat$2.00+507.7%N/A$29.74MN/A-0.16190 Related Companies and Tools Related Companies LTRN Alternatives KZR Alternatives OKUR Alternatives BDRX Alternatives RNTX Alternatives KALA Alternatives MRNS Alternatives EYEN Alternatives DYAI Alternatives ALLK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEON) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
